FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146770164> ?p ?o ?g. }

• W2146770164 endingPage "962" @default.
• W2146770164 startingPage "957" @default.
• W2146770164 abstract "Initial results of a randomized trial comparing carboplatin with radiotherapy (RT) as adjuvant treatment for stage I seminoma found carboplatin had a noninferior relapse-free rate (RFR) and had reduced contralateral germ cell tumors (GCTs) in the short-term. Updated results with a median follow-up of 6.5 years are now reported.Random assignment was between RT and one infusion of carboplatin dosed at 7 × (glomerular filtration rate + 25) on the basis of EDTA (n = 357) and 90% of this dose if determined on the basis of creatinine clearance (n = 202). The trial was powered to exclude a doubling in RFRs assuming a 96-97% 2-year RFR after radiotherapy (hazard ratio [HR], approximately 2.0).Overall, 1,447 patients were randomly assigned in a 3-to-5 ratio (carboplatin, n = 573; RT, n = 904). RFRs at 5 years were 94.7% for carboplatin and 96.0% for RT (RT-C 90% CI, 0.7% to 3.5%; HR, 1.25; 90% CI, 0.83 to 1.89). One death as a result of seminoma (in RT arm) occurred. Patients receiving at least 99% of the 7 × AUC dose had a 5-year RFR of 96.1% (95% CI, 93.4% to 97.7%) compared with 92.6% (95% CI, 88.0% to 95.5%) in those who received lower doses (HR, 0.51; 95% CI, 0.24 to 1.07; P = .08). There was a clear reduction in the rate of contralateral GCTs (carboplatin, n = 2; RT, n = 15; HR, 0.22; 95% CI, 0.05 to 0.95; P = .03), and elevated pretreatment follicle-stimulating hormone (FSH) levels (> 12 IU/L) was a strong predictor (HR, 8.57; 95% CI, 1.82 to 40.38).These updated results confirm the noninferiority of single dose carboplatin (at 7 × AUC dose) versus RT in terms of RFR and establish a statistically significant reduction in the medium term of risk of second GCT produced by this treatment." @default.
• W2146770164 created "2016-06-24" @default.
• W2146770164 creator A5009234043 @default.
• W2146770164 creator A5018500317 @default.
• W2146770164 creator A5019086869 @default.
• W2146770164 creator A5023188445 @default.
• W2146770164 creator A5031832649 @default.
• W2146770164 creator A5047753094 @default.
• W2146770164 creator A5066576612 @default.
• W2146770164 creator A5066606548 @default.
• W2146770164 creator A5071786386 @default.
• W2146770164 date "2011-03-10" @default.
• W2146770164 modified "2023-10-10" @default.
• W2146770164 title "Randomized Trial of Carboplatin Versus Radiotherapy for Stage I Seminoma: Mature Results on Relapse and Contralateral Testis Cancer Rates in MRC TE19/EORTC 30982 Study (ISRCTN27163214)" @default.
• W2146770164 cites W1978174896 @default.
• W2146770164 cites W2018607314 @default.
• W2146770164 cites W2031876915 @default.
• W2146770164 cites W2042669500 @default.
• W2146770164 cites W2046318933 @default.
• W2146770164 cites W2065086317 @default.
• W2146770164 cites W2074973675 @default.
• W2146770164 cites W2078892640 @default.
• W2146770164 cites W2085153854 @default.
• W2146770164 cites W2089925296 @default.
• W2146770164 cites W2098915440 @default.
• W2146770164 cites W2100533308 @default.
• W2146770164 cites W2105475112 @default.
• W2146770164 cites W2120873957 @default.
• W2146770164 cites W2136265852 @default.
• W2146770164 cites W2140134446 @default.
• W2146770164 cites W2140462124 @default.
• W2146770164 cites W2140944538 @default.
• W2146770164 cites W2147660097 @default.
• W2146770164 cites W2148115138 @default.
• W2146770164 cites W2162760243 @default.
• W2146770164 cites W2165322136 @default.
• W2146770164 cites W2165939716 @default.
• W2146770164 cites W2218229785 @default.
• W2146770164 cites W2219851884 @default.
• W2146770164 cites W2230503432 @default.
• W2146770164 cites W2299405794 @default.
• W2146770164 cites W2574309644 @default.
• W2146770164 cites W4249100950 @default.
• W2146770164 cites W4301321179 @default.
• W2146770164 cites W4361742796 @default.
• W2146770164 doi "https://doi.org/10.1200/jco.2009.26.4655" @default.
• W2146770164 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21282539" @default.
• W2146770164 hasPublicationYear "2011" @default.
• W2146770164 type Work @default.
• W2146770164 sameAs 2146770164 @default.
• W2146770164 citedByCount "264" @default.
• W2146770164 countsByYear W21467701642012 @default.
• W2146770164 countsByYear W21467701642013 @default.
• W2146770164 countsByYear W21467701642014 @default.
• W2146770164 countsByYear W21467701642015 @default.
• W2146770164 countsByYear W21467701642016 @default.
• W2146770164 countsByYear W21467701642017 @default.
• W2146770164 countsByYear W21467701642018 @default.
• W2146770164 countsByYear W21467701642019 @default.
• W2146770164 countsByYear W21467701642020 @default.
• W2146770164 countsByYear W21467701642021 @default.
• W2146770164 countsByYear W21467701642022 @default.
• W2146770164 countsByYear W21467701642023 @default.
• W2146770164 crossrefType "journal-article" @default.
• W2146770164 hasAuthorship W2146770164A5009234043 @default.
• W2146770164 hasAuthorship W2146770164A5018500317 @default.
• W2146770164 hasAuthorship W2146770164A5019086869 @default.
• W2146770164 hasAuthorship W2146770164A5023188445 @default.
• W2146770164 hasAuthorship W2146770164A5031832649 @default.
• W2146770164 hasAuthorship W2146770164A5047753094 @default.
• W2146770164 hasAuthorship W2146770164A5066576612 @default.
• W2146770164 hasAuthorship W2146770164A5066606548 @default.
• W2146770164 hasAuthorship W2146770164A5071786386 @default.
• W2146770164 hasConcept C126322002 @default.
• W2146770164 hasConcept C126894567 @default.
• W2146770164 hasConcept C143998085 @default.
• W2146770164 hasConcept C168563851 @default.
• W2146770164 hasConcept C207103383 @default.
• W2146770164 hasConcept C2776694085 @default.
• W2146770164 hasConcept C2778074268 @default.
• W2146770164 hasConcept C2778239845 @default.
• W2146770164 hasConcept C2781451048 @default.
• W2146770164 hasConcept C44249647 @default.
• W2146770164 hasConcept C509974204 @default.
• W2146770164 hasConcept C71924100 @default.
• W2146770164 hasConceptScore W2146770164C126322002 @default.
• W2146770164 hasConceptScore W2146770164C126894567 @default.
• W2146770164 hasConceptScore W2146770164C143998085 @default.
• W2146770164 hasConceptScore W2146770164C168563851 @default.
• W2146770164 hasConceptScore W2146770164C207103383 @default.
• W2146770164 hasConceptScore W2146770164C2776694085 @default.
• W2146770164 hasConceptScore W2146770164C2778074268 @default.
• W2146770164 hasConceptScore W2146770164C2778239845 @default.
• W2146770164 hasConceptScore W2146770164C2781451048 @default.
• W2146770164 hasConceptScore W2146770164C44249647 @default.
• W2146770164 hasConceptScore W2146770164C509974204 @default.
• W2146770164 hasConceptScore W2146770164C71924100 @default.
• W2146770164 hasIssue "8" @default.

• next